deltatrials
Unknown OBSERVATIONAL NCT01567449

Risk Factors for Aneurysm Rebleeding

Risk Factors in Predicting Spontaneous Intracranial Aneurysm Rebleeding During Hospitalization

Sponsor: Fujian Medical University

Updated 7 times since 2017 Last updated: Mar 28, 2012 Started: Sep 30, 2011 Primary completion: Mar 31, 2012 Completion: Apr 30, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Subarachnoid Hemorrhage, Aneurysmal and is currently ongoing. Fujian Medical University leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotUnknown Status~Feb 2017 – ~Apr 2018 · 14 months · monthly snapshotUnknown Status~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown StatusUnknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status

  5. Apr 2018 — Jun 2018 [monthly]

    Unknown Status

    Phase: NANone

Show 2 earlier versions
  1. Feb 2017 — Apr 2018 [monthly]

    Unknown Status NA

  2. Jan 2017 — Feb 2017 [monthly]

    Unknown Status NA

    First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fujian Medical University
Data source: Fujian Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations